Skip to main content

Table 1 Panel of RDT brands used in the study

From: Prozone in malaria rapid diagnostics tests: how many cases are missed?

Brands/manufacturers and Lot numbers

Format and Plasmodium antigens targeted (P. falciparum target is underlined)

WHO FIND Procurement list *

WHO FIND Evaluation

ICT Malaria ICT Diagnostics, Cape Town, South Africa

Lot n°: 32784

Two-band: HRP-2

yes

yes

Paracheck-Pf Orchid Biomedical Systems, Goa, India

Lot n°: A31003, 31672, 32972, 31797

Two-band: HRP-2

yes

yes

SD Malaria Antigen Pf FK50 Standard Diagnostics, Hagal-Dong, Korea

Lot n°: 082011, 082012, 080216

Two-band: HRP-2

yes

yes

SD Malaria Ag Pf/Pan FK60 Standard Diagnostics, Hagal-Dong, Korea

Lot n°: 090008, 090010, 090026

Three-band: HRP-2, pan-pLDH

yes

yes

Hexagon Malaria Combi Human Wiesbaden, Germany

Lot n°: 80930

Three-band: HRP-2, aldolase

no

yes

Malaria Pan/Pv/Pf Rapid Device Biotec laboratories Ltd., Ipswitch, UK

Lot n°: 91081, 91100

Four-band: HRP-2, Pan-pLDH, Pv-pLDH

no

no

CareStart Malaria pLDH Acces Bio, New Jersey, USA

Lot n°: B191L, A101L

Three-band: Pf-pLDH, pan-pLDH

no

yes

SD Malaria pLDH FK40 Standard Diagnostics, Hagal-Dong, Korea

Lot n°: 081006

Three-band: Pf-pLDH, pan-pLDH

no

yes

First Response Malaria Ag Combo $

Premier Medical Coorporation Ltd., Daman, India

Lot n°: 6900309

Three-band: HRP-2, Pan-pLDH

yes

yes

Hexagon Malaria $

Human, Wiesbaden, Germany

Lot n°: 0001

Two-band:: HRP-2

no

yes

ICT Malaria Combo $

ICT Diagnostics, Cape Town, South Africa

Lot n°: 32250

Three-band: HRP-2, Aldolase

no

yes

Malaria Total Quick $

Cypress Diagnostics, Leuven, Belgium

Lot n°: 090002

Three-band:HRP-2, Pan-PLDH

no

no

  1. * Included in the interim selection for procurement of malaria rapid diagnostic test [43].
  2. Evaluated by WHO/FIND [16, 17].
  3. RDTs assessed for prozone on stored samples at the end of the study.
  4. $ Additional panel of RDTs assessed at the end of the study with a subset of stored samples positive for prozone for at least one of the prospectively assessed HRP-2 RDTs.